Biocon Biologics Garners $75m ADQ Investment

Biocon Subsidiary Now Valued At More Than $4bn After Private Equity Deal

 
• By Dave Wallace

Biocon has secured the latest in a series of investments in its Biocon Biologics subsidiary, from Abu Dhabi based ADQ. The transaction, worth around $75m, values the biosimilars unit at $4.17bn.

Money Dollars Injection Investment
Biocon Biologics has received a further injection of capital • Source: Shutterstock

More from Deals

More from Business